surgery and semaglutide delivers substantial weight loss after suboptimal bariatric response, study finds SURGERY and OZEMPIC you must

NICE guidelines (NG28) recommend reviewing GLP-1 treatment at around 6 months and continuing only if there has been a meaningful reduction in HbA1c (typically at least 11 mmol/mol [1%]) and weight loss of at least 3% of initial body weight

Flatulence is generally less frequent than other GI effects, while diarrhea has been reported by roughly 30% of patients in some sources, so timely hydration strategies and clinician communication matter

No, Ozempic (semaglutide) is not listed as causing yeast infections in UK prescribing information

Long-Term Success: A Holistic Approach Effective, long-term weight management extends beyond medication